<DOC>
	<DOCNO>NCT01180751</DOCNO>
	<brief_summary>This clinical trial conduct study use radioactive glucose tracer image test [ Positron Emission Tomography ( PET ) scan ] adult suspect cancer another group adults assess neurologic condition .</brief_summary>
	<brief_title>18F-Fluorodeoxyglucose Positron Emission Tomography Oncology Neurology</brief_title>
	<detailed_description />
	<mesh_term>Deoxyglucose</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>Known suspected primary metastatic tumour A neurological presentation consistent list indication 18 year age old either sex Able provide write informed consent Able tolerate physical logistical requirement complete Positron Emission Tomography ( PET ) scan Karnofsky score &gt; 60 Women nursing may include study able discontinue breast feed 12 hour Age &lt; 18 year Pregnant woman ; possibility pregnancy , bloodwork drawn definitively establish pregnancy status Women unwilling unable discontinue breast feed 12 hour post 18FFluorodeoxyglucose ( FDG ) administration Subjects medically unstable Subjects unwilling provide inform consent . Subjects exceed safe weight limit Positron Emission Tomography ( PET ) image bed fit PET scanner bore</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Positron Emission Tomography</keyword>
	<keyword>Fluorodeoxyglucose</keyword>
	<keyword>FDG ( 18F-Fluorodeoxyglucose )</keyword>
	<keyword>Oncology</keyword>
	<keyword>Neurology</keyword>
</DOC>